Advancience is a startup from Basel with a focus on digital tools for psychology. Christian Vogler, Leo Gschwind, Andy Aeberhard and Marko Obradovic co-founded Advancience in 2019 to build upon a joint research project from the founders. The company uses data that is gathered while playing computer games to measure cognitive functions, which for example can help to diagnose psychiatric disorders.
Aurteen is based in Alberta, Canada and develops software that improves the detection, monitoring and treatment of retinopathy with preterm infants, which is the leading cause of preventable childhood blindness worldwide. Founder and director Faraz Oloumi is an expert in retinal image analysis. Aurteen hopes to collaborate with clinical and technical experts in the Basel area to bring its software closer to commercialization.
Noul from South Korea works with the Swiss Tropical and Public Health Institute (Swiss TPH) to improve the diagnosis of Malaria, a major cause of death among children in low and middle income countries. The Noul team have developed a portable device that uses image analysis combined with artificial intelligence to diagnose diseases from blood samples. In addition to their work with the DayOne Accelerator, they will be working with the Swiss TPH and the University of Basel to improve performance of their machines, for example doing clinical trials jointly and enhancing AI learning algorithms including enhancement of AI algorithms.